---
title: "Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)"
nct_id: NCT02039297
overall_status: COMPLETED
phase: NA
sponsor: Mayo Clinic
study_type: INTERVENTIONAL
primary_condition: Critical Illness
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02039297.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02039297"
ct_last_update_post_date: 2017-10-24
last_seen_at: "2026-05-12T06:06:55.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)

**NCT ID:** [NCT02039297](https://clinicaltrials.gov/study/NCT02039297)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 7813
- **Lead Sponsor:** Mayo Clinic
- **Collaborators:** Centers for Medicare and Medicaid Services
- **Conditions:** Critical Illness, Sepsis, Respiratory Failure, Shock, Coma, Bleeding, Trauma
- **Start Date:** 2013-03
- **Completion Date:** 2017-06
- **CT.gov Last Update:** 2017-10-24

## Brief Summary

In this multicenter project, we will introduce AWARE (electronic interface) Using a cloud-based technology . The goal of this project is to improve compliance with best practice through the use of a new acute care interface with built-in tools for error prevention, practice surveillance and reporting (ProCCESs AWARE - Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation).The goal of this project is to develop and test a novel acute care interface with built-in tools for error prevention, practice surveillance, decision support and reporting (ProCCESs AWARE - Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation). In preliminary studies, these novel informatics supports built on an advanced understanding of cognitive and organizational ergonomics, have significantly decreased the cognitive load of bedside providers and reduced medical errors. Using a cloud-based technology, AWARE will be uniformly available on either mobile or fixed computing devices and applied in a standardized manner in medical and surgical ICUs of five geographically diverse acute care hospitals predominantly serving Medicare and Medicaid patients. The impact of ProCCESs AWARE on processes of care and outcomes in study ICUs; expected to enroll more than 10,000 critically ill patients during the study period.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

For the Primary Objective, all critically ill adult patient admitted to an ICU participating in the study will be eligible.

Exclusion Criteria:

For the Primary Objective, all children younger than 18years of age will be excluded.
```

## Arms

- **No Intervention: Baseline arm** (OTHER) — Pre and post design (same arm)

## Interventions

- **Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation** (OTHER) — Computer aided checklist and rounding tool implemented in the Intensive care unit environment

## Primary Outcomes

- **Adherence to process of care** _(time frame: Participants will be followed for the duration of ICU stay, an expected average of 3 days)_ — Adherence to best practice for daily intensive care rounds. Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis etc.

## Secondary Outcomes

- **Patient outcomes** _(time frame: Hospital length of stay - 2 weeks)_

## Locations (6)

- Mayo Clinic Arizona, Scottsdale, Arizona, United States
- Mayo Clinic, Jacksonville, Florida, United States
- Lawrence Genral Hospital, Lawrence, Massachusetts, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
- Montefiore Medical Center, The Bronx, New York, United States
- OU Medical center, Oklahoma City, Oklahoma, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.mayo clinic arizona|scottsdale|arizona|united states` — added _(2026-05-12)_
- `locations.mayo clinic|jacksonville|florida|united states` — added _(2026-05-12)_
- `locations.lawrence genral hospital|lawrence|massachusetts|united states` — added _(2026-05-12)_
- `locations.mayo clinic in rochester|rochester|minnesota|united states` — added _(2026-05-12)_
- `locations.montefiore medical center|the bronx|new york|united states` — added _(2026-05-12)_
- `locations.ou medical center|oklahoma city|oklahoma|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02039297.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02039297*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*